Since the majority of pancreatic adenocarcinomas are associated with KRAS mutations and the pattern of metastasis to the lung of pancreatic carcinoma often mimics bronchioalveolar carcinoma, we feel that KRAS mutational analysis can be a useful adjunct to definitively determine the site of origin. Here, KRAS is linked to lung adenocarcinoma in situ.